Rituximab as preventive therapy of a clinical relapse in TTP with ADAMTS13 inhibitor
Open Access
- 31 January 2007
- journal article
- letter
- Published by Wiley in American Journal of Hematology
- Vol. 82 (5), 417-418
- https://doi.org/10.1002/ajh.20764
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 casesBlood, 2005
- Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case reportBlood, 2005
- Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximabAmerican Journal of Hematology, 2002
- Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic PurpuraNew England Journal of Medicine, 1998